$1.96
0.03[1.55%]
Last update: 9:30AM Get Real Time Here
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
Date Announced | ticker | Company Name | Period | Period Year | Min EPS | Max EPS | Estimate | Min Rev | Max Rev | Revenue Estimate | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
01/10/2024 | CHRS | Coherus BioSciences | Q4 | 2023 | — | — | — | $90.00M | — | $95.68M | Get Alert |
01/10/2024 | CHRS | Coherus BioSciences | FY | 2023 | — | — | — | $260.00M | $260.00M | $260.53M | Get Alert |
11/06/2023 | CHRS | Coherus BioSciences | FY | 2023 | — | — | — | $250.00M | $260.00M | $288.19M | Get Alert |
08/02/2023 | CHRS | Coherus BioSciences | FY | 2023 | — | — | — | $275.00M | — | $266.16M | Get Alert |
05/08/2023 | CHRS | Coherus BioSciences | FY | 2023 | — | — | — | $275.00M | — | $344.75M | Get Alert |
04/13/2020 | CHRS | Coherus BioSciences | Q1 | 2020 | — | — | — | $115.00M | $117.50M | $118.85M | Get Alert |
There have been no specific sales or earnings guidance reported for Coherus BioSciences in recent months.
Browse guidance and forecast on all stocks.